X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5582) 5582
Publication (544) 544
Book Chapter (74) 74
Book Review (55) 55
Book / eBook (31) 31
Conference Proceeding (12) 12
Dissertation (10) 10
Web Resource (3) 3
Paper (1) 1
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3729) 3729
animals (2333) 2333
index medicus (1718) 1718
complement (1588) 1588
immunology (1563) 1563
male (1445) 1445
female (1444) 1444
complement activation (1069) 1069
adult (864) 864
mice (694) 694
middle aged (628) 628
hemolysis (570) 570
activation (538) 538
complement hemolytic activity assay (494) 494
biochemistry & molecular biology (487) 487
proteins (480) 480
complement system proteins - immunology (417) 417
complement system proteins - metabolism (390) 390
adolescent (389) 389
analysis (388) 388
aged (377) 377
child (355) 355
complement system proteins - analysis (353) 353
antibodies (349) 349
hemolytic-uremic syndrome (347) 347
enzyme-linked immunosorbent assay (345) 345
rats (340) 340
rabbits (334) 334
alternative pathway (328) 328
complement activation - drug effects (302) 302
disease (298) 298
hematology (286) 286
erythrocytes - immunology (285) 285
research (284) 284
complement c3 - metabolism (278) 278
inflammation (278) 278
guinea pigs (270) 270
research article (255) 255
complement system (254) 254
complement pathway, alternative (252) 252
protein binding (250) 250
complement c3 - analysis (248) 248
article (245) 245
mutation (244) 244
sheep (241) 241
child, preschool (235) 235
complement system proteins (231) 231
time factors (225) 225
complement activation - immunology (217) 217
health aspects (216) 216
phagocytosis (216) 216
lupus erythematosus, systemic - immunology (215) 215
urology & nephrology (215) 215
genetic aspects (205) 205
eculizumab (204) 204
pharmacology & pharmacy (204) 204
molecular sequence data (202) 202
medicine, research & experimental (200) 200
in vitro techniques (194) 194
expression (192) 192
transplantation (192) 192
veterinary sciences (190) 190
complement pathway, classical (187) 187
medicine (187) 187
system (186) 186
physiological aspects (183) 183
complement fixation tests (180) 180
rheumatology (180) 180
cells, cultured (179) 179
hemolysis - drug effects (179) 179
amino acid sequence (177) 177
autoantibodies (176) 176
innate immunity (175) 175
microbiology (175) 175
pediatrics (175) 175
immune system (174) 174
cells (172) 172
deficiency (169) 169
multidisciplinary sciences (168) 168
binding (167) 167
systemic lupus erythematosus (166) 166
cell biology (164) 164
complement c3 - immunology (164) 164
electrophoresis, polyacrylamide gel (164) 164
risk factors (164) 164
complement factor h (163) 163
protein (163) 163
immunoglobulin g (162) 162
infant (161) 161
macular degeneration (161) 161
complement factor h - genetics (160) 160
disease models, animal (159) 159
factor-h (159) 159
medicine & public health (159) 159
serum (158) 158
erythrocytes (157) 157
immunoglobulins (156) 156
molecular weight (156) 156
young adult (153) 153
blood (152) 152
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5539) 5539
Japanese (44) 44
French (15) 15
Russian (15) 15
Spanish (9) 9
Portuguese (8) 8
Chinese (5) 5
Polish (4) 4
German (3) 3
Croatian (2) 2
Ukrainian (2) 2
Dutch (1) 1
Italian (1) 1
Korean (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0124655
For thrombotic microangiopathies (TMAs), the diagnosis of atypical hemolytic uremic syndrome (aHUS) is made by ruling out Shiga toxin-producing Escherichia... 
FACTOR-H AUTOANTIBODIES | COMPLEMENT | PROTECTION | ABNORMALITIES | PROMOTERS | MULTIDISCIPLINARY SCIENCES | THROMBOTIC THROMBOCYTOPENIC PURPURA | MICROANGIOPATHIES | UNIVERSITY | SACCHAROMYCES-CEREVISIAE | EXPRESSION | Erythrocytes - immunology | Genetic Predisposition to Disease | Humans | Japan | Asian Continental Ancestry Group - genetics | Male | Atypical Hemolytic Uremic Syndrome - immunology | Complement Hemolytic Activity Assay - methods | Animals | Complement Factor H - metabolism | Polymorphism, Restriction Fragment Length | Female | Sheep - blood | Atypical Hemolytic Uremic Syndrome - diagnosis | Antibodies, Monoclonal - metabolism | Mutation | Complement Factor H - genetics | Atypical Hemolytic Uremic Syndrome - genetics | Complement C3 - genetics | Early Diagnosis | Sheep - immunology | Blood transfusions | Plasma | Pediatrics | Shiga toxin | Transplants & implants | Laboratories | Pathogenesis | Erythrocytes | Infections | Complement | Kinases | Assaying | Medical diagnosis | Proteins | Genetic abnormalities | Complement factor H | Thrombotic thrombocytopenic purpura | Red blood cells | E coli | Life sciences | Diagnosis | Hemolysis | Hemolytic uremic syndrome | Abnormalities | Blood cells | Patients | Thrombocytopenic purpura | Sheep red blood cells | Complement activation | Restriction fragment length polymorphism | Cellular biology | Purpura | Complement component C3 | Monoclonal antibodies | Sheep | Polymorphism
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 4, pp. 518 - 525
Abstract We recently observed that dysregulation of the complement system may be involved in the pathogenesis of hematopoietic stem cell... 
Hematology, Oncology and Palliative Medicine | Hematopoietic stem cell transplant | Eculizumab | Thrombotic microangiopathy | Eculizumab pharmacokinetics | CH50 | DIAGNOSIS | LONG-TERM SURVIVORS | COMPLEMENT | HEMOLYTIC-UREMIC SYNDROME | IMMUNOLOGY | TRANSPLANTATION | GLOMERULAR-FILTRATION-RATE | Hematopoietic stem cell | CYSTATIN-C | transplant | Eculizumab pharrnacokinetics | CHRONIC KIDNEY-DISEASE | HYPERTENSION | HEMATOLOGY | CHSO | Hematologic Neoplasms - therapy | Severity of Illness Index | Complement Hemolytic Activity Assay | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Hematologic Neoplasms - mortality | Humans | Child, Preschool | Complement Membrane Attack Complex - antagonists & inhibitors | Thrombotic Microangiopathies - mortality | Transplantation, Autologous | Hematologic Neoplasms - pathology | Transplantation, Homologous | Drug Dosage Calculations | Complement Inactivating Agents - therapeutic use | Hematopoietic Stem Cell Transplantation - adverse effects | Survival Analysis | Hematologic Neoplasms - immunology | Thrombotic Microangiopathies - etiology | Drug Monitoring | Child | Thrombotic Microangiopathies - immunology | Thrombotic Microangiopathies - drug therapy | Hypertension | Enzymes | Mortality | Stem cells | Transplantation | Children | Health aspects | Hematopoietic stem cells
Journal Article
Biochemia medica, ISSN 1330-0962, 10/2019, Volume 29, Issue 3, pp. 030701 - 505
Complement functional analyses provide insight into the integrity of the entire complement reaction cascade. These tests are suitable for investigating... 
alternative and classical complement pathway | complement haemolytic activity assay | complement C3d | preanalytical phase | complement C3 | Original
Journal Article
Kidney International, ISSN 0085-2538, 11/2012, Volume 82, Issue 10, pp. 1084 - 1092
Journal Article
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 04/2010, Volume 207, Issue 4, pp. 793 - 806
Journal Article
Journal Article
Patologicheskaia fiziologiia i eksperimental'naia terapiia, ISSN 0031-2991, 10/2013, Issue 4, p. 115
The authors developed a new indicator of humoral immunity, which characterizes the complement system reactivity (CSR). Complement system reactivity has been... 
Humans | Complement Hemolytic Activity Assay - methods
Journal Article
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2008, Volume 199, Issue 5, pp. 484.e1 - 484.e4
Journal Article